Mobocertinib is a small molecule tyrosine kinase inhibitor. Its molecular target is epidermal growth factor receptor (EGFR) bearing mutations in…
[Indications] Giefoni is a tyrosine kinase inhibitor (TKI) used in the first-line treatment of patients with…